Leonard Sank is Director at ORAMED PHARMACEUTICALS INC. (ORMP). They have made 8 open-market trades across 2 companies since 2007, most recently 2025-06-05.
CIK 0001416089
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $659K since 2007, never a sale. Across 7 scored buys the stock is up 5.5% at ninety days, and 5.1 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 29% | 14% |
| Avg Move | -9.4% | -2.0% | +5.5% |
| Alpha | -6.0% | -0.7% | +5.1% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORMP | BUY | 2019-09-09 | 2019-09-11 | $2.92 | $73K | +11.1% | +4.0% | +67.1% |
| ORMP | BUY | 2019-07-16 | 2019-07-18 | $3.59 | $196K | -7.8% | -18.0% | -21.5% |
| ORMP | BUY | 2019-07-11 | 2019-07-15 | $3.22 | $4K | +12.0% | +0.6% | -6.6% |
| ORMP.OB | BUY | 2011-10-04 | 2011-10-06 | $0.32 | $300K | N/A | N/A | N/A |
| ORMP | BUY | 2008-01-15 | 2008-01-17 | $0.25 | $5K | -20.4% | -0.1% | -0.1% |
| ORMP | BUY | 2008-01-07 | 2008-01-09 | $0.30 | $7K | -20.4% | -0.1% | -0.1% |
| ORMP | BUY | 2008-01-03 | 2008-01-07 | $0.30 | $14K | -20.4% | -0.1% | -0.1% |
| ORMP | BUY | 2007-12-31 | 2008-01-03 | $0.27 | $59K | -20.4% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.